Companies: 10,795·Total market cap: $144.5T
Bionoid Pharma, Inc.

Bionoid Pharma, Inc.

BINPOTCHealthcare
$0.03
$-0.00(-0.00%)
Market Cap$1619838
P/E Ratio
52W High$0.448
52W Low$0.0162

Bionoid Pharma, Inc.(BINP)· 损益表

年度 / 季度 / TTM 视图 · SEC 10-K 与 10-Q(经 FMP 聚合)· 可在下方切换周期与 M/B/T 单位。

FMP · BINP · 截至 2026-06-09

财务报表

Revenue · Gross Profit · Net Income
Breakdown2024-122023-122022-122021-122020-12
Revenue
Revenue$0.00B$0.00B$0.00B$0.00B$0.00B
Cost of Revenue$0.00B$0.00B$0.00B$0.00B$0.00B
Gross Profit($0.00B)$0.00B$0.00B$0.00B$0.00B
Gross Margin %(computed)22.44%48.13%45.05%45.90%
Operating Expenses
R&D Expenses$0.00B$0.00B$0.00B$0.00B$0.00B
G&A Expenses$0.00B$0.00B$0.00B$0.00B$0.00B
Total Operating Expenses$0.00B$0.00B$0.00B$0.00B$0.00B
Operating Income($0.00B)$0.00B$0.00B($0.00B)($0.00B)
Operating Margin %(computed)35.99%5.16%-78.17%-105.95%
Interest Income$0.00B$0.00B$0.00B$0.00B$0.00B
Interest Expense$0.00B$0.00B$0.00B$0.00B$0.00B
Income Before Tax($0.00B)$0.00B$0.00B($0.00B)($0.00B)
Income Tax Expense$0.00B($0.00B)$0.00B$0.00B$0.00B
Net Income($0.00B)$0.00B$0.00B($0.00B)($0.00B)
Net Margin %(computed)31.26%4.10%-132.20%
Per Share & EBITDA
EPS (Basic)$-0.01$-0.00$0.00$-0.00$-11.88
Wtd Avg Shares0.05B0.05B0.05B0.04B0.00B
EBITDA$0.00B($0.00B)$0.00B($0.00B)($0.00B)
EBITDA Margin %(computed)-11.53%13.48%-129.26%-96.16%

数据来源:Financial Modeling Prep · 最后更新:2026-06-09 · USD · B

深入了解Bionoid Pharma, Inc.

关于Bionoid Pharma, Inc.(BINP)损益表

Bionoid Pharma, Inc.(BINP)损益表数据来源于SEC Form 10-K及10-Q申报文件。2024财年,BINP实现营收$0.00B,毛利润($0.00B)(毛利率—),净利润($0.00B)(净利率—)。

常见问题

BINP · 4 问

Bionoid Pharma, Inc.(BINP)2024财年营收为$0.00B,同比down100.0%。

BINP revenueBINP salesannual revenue YoYincome statement

· Source: FMP /stable/income-statement · SEC EDGAR Form 10-K & 10-Q · As of 2026-06-09